Nanobiotix S.A. (NBTX) Form 6-K Summary

This filing for Nanobiotix S.A., dated November 3, 2025, reports the issuance of a press release on the same date (Exhibit 99.1).

• Investor Focus: Investors must review Exhibit 99.1 as it contains the material information for this filing month.
• Context: This 6-K is a standard mechanism for foreign private issuers to submit significant ongoing disclosures.
• Signatory: The filing was certified by CFO Bart Van Rhijn.

Critical Action: Review Exhibit 99.1 for specific business updates, financial metrics, or str